Allison K. Cabalka
Mayo Clinic
RadiologySurgeryCardiologyHemodynamicsMitral valve replacementPatent foramen ovaleCardiac catheterizationMitral valveHeart failureStentPulmonary valveTricuspid valveStenosisHeart diseaseRegurgitation (circulation)PercutaneousCatheterMitral regurgitationMedicineComplication
119Publications
30H-index
3,079Citations
Publications 127
Newest
#1Jacqueline Kreutzer (University of Pittsburgh)H-Index: 14
#2Aimee K. Armstrong (Nationwide Children's Hospital)H-Index: 12
Last. Doff B. McElhinney (Stanford University)H-Index: 23
view all 19 authors...
Objective We compared 5-year outcomes of transcatheter pulmonary valve (TPV) replacement with the Melody TPV in the post-approval study (PAS) and the investigational device exemption (IDE) trial. Background As a condition of approval of the Melody TPV after the IDE trial, the Food and Drug Administration required that a PAS be conducted to evaluate outcomes of TPV replacement in a "real-world" environment. The 5-year outcomes of the PAS have not been published, and the IDE and PAS trials have no...
Source
Source
#1Jason H. Anderson (Mayo Clinic)H-Index: 5
#2Doff B. McElhinney (Stanford University)H-Index: 23
Last. Vivid RegistryH-Index: 1
view all 11 authors...
Abstract Objectives The aim of this study was to determine the prevalence of pacemaker lead–related complications following transcatheter tricuspid valve replacement (TTVR). Background The rate of permanent pacemaker implantation following tricuspid valve (TV) surgery is high, and many patients have transvenous leads. The feasibility, safety, and outcomes of subsequently performing TTVR in the setting of transvenous pacemaker leads have not been established. Methods The VIVID (Valve-in-Valve Int...
4 CitationsSource
#1Mohamad Alkhouli (Mayo Clinic)H-Index: 20
#2Sorin V. Pislaru (Mayo Clinic)H-Index: 35
Last. Allison K. Cabalka (Mayo Clinic)H-Index: 30
view all 4 authors...
Source
#1Muhammad Yasir Qureshi (Mayo Clinic)H-Index: 9
#2Nathaniel W. Taggart (Mayo Clinic)H-Index: 12
Last. Timothy J. Nelson (Mayo Clinic)H-Index: 35
view all 10 authors...
The increased workload on single right ventricle (sRV) leads to increased risk of Fontan failure due to ventricular dysfunction. Conventional heart failure therapy has mixed results. This has led to increased interest in seeking alternative therapeutic strategies to improve ventricular function
Source
Background: Transcatheter mitral valve replacement using aortic transcatheter heart valves has recently become an alternative for patients with degenerated mitral bioprostheses, failed surgical rep...
#1Mayra Guerrero (Mayo Clinic)H-Index: 19
#2Sreekanth Vemulapalli (Durham University)H-Index: 33
Last. Ted Feldman (NorthShore University HealthSystem)H-Index: 76
view all 33 authors...
BACKGROUND: Transcatheter mitral valve replacement using aortic transcatheter heart valves has recently become an alternative for patients with degenerated mitral bioprostheses, failed surgical repairs with annuloplasty rings or severe mitral annular calcification who are poor surgical candidates. Outcomes of these procedures are collected in the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry. A comprehensive analysis of mitral valve-in-valve (MV...
41 CitationsSource
#1Bassim El-Sabawi (Mayo Clinic)H-Index: 6
#2Mohammed Al-Hijji (Mayo Clinic)H-Index: 10
Last. Charanjit S. Rihal (Mayo Clinic)H-Index: 80
view all 9 authors...
OBJECTIVES: To evaluate the outcomes of transcatheter coronary artery fistula (CAF) closure and to identify anatomic/procedural factors that may impact outcomes. BACKGROUND: Due to the rarity of CAF, reported experience with transcatheter closure remains limited and anatomic and procedural factors that may lead to unsuccessful closure, complications, or recanalization of CAF are unclear. METHODS: All patients who underwent transcatheter CAF closure at Mayo Clinic from 1997 to 2018 were retrospec...
2 CitationsSource